【ChiCTR1800017602】Analgesic Efficacy of Erector Spinae Plane Block after Percutaneous Nephrolithotomy: A Prospective Randomized Controlled Clinical Trial
ChiCTR1800017602
正在进行
/
/
/
2018-08-06
/
/
postoperative pain control
Analgesic Efficacy of Erector Spinae Plane Block after Percutaneous Nephrolithotomy: A Prospective Randomized Controlled Clinical Trial
Analgesic Efficacy of Erector Spinae Plane Block after Percutaneous Nephrolithotomy: A Prospective Randomized Controlled Clinical Trial
21461
Proper controlling of postoperative pain after percutaneous nephrolithotomy procedure by doing ultrasound-guided erector spinae plane block (ESPB) at the level of the thoracic vertebra number 11.
随机平行对照
治疗新技术
Patients were randomized with a 1:1 allocation ratio. The allocated intervention was written on a slip of paper, placed in sealed serially numbered and opaque envelopes. The envelopes were serially opened to determine which group the patient would be included in. The anesthesiologist performing the randomization (A
Both investigators and patients were blind to which method was being used.
Dr. Soliman Fakeeh Hospital
/
25
/
2017-09-02
2018-12-01
/
Inclusion criteria were patients with American Society of Anesthesiologists (ASA) physical status Classes I and II, aged 18–65 years, and scheduled for first-stage unilateral PCNL to extract stones which are large, multiple, or resistant to shockwave lithotripsy from the upper ureter and the pelvicalyceal system.；
请登录查看The exclusion criteria included patients with psychological disorders, morbid obesity, hepatic or renal dysfunction, coagulation disorders, sepsis, history of chronic analgesic use, and history of allergy to local anesthetics.；
请登录查看Dr. Soliman Fakeeh Hospital
21461
Dr. Soliman Fakeeh Hospital的其他临床试验
Zagazig University, Egypt的其他临床试验
最新临床资讯
-
飞眸医疗首例人体临床试验（FIH）成功开展，国产飞秒屈光设备竞逐540亿屈光市场
动脉网-最新2026-09-10
-
和铂医药：超长效靶向TSLP抗体哮喘二期临床取得阳性结果，三期临床已启动
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
动脉网-最新2026-09-09
-
药明康德2026-09-09
-
一度医药2026-09-08
-
阿斯利康中国2026-09-08
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-09-26
-
2026-09-26
-
2026-09-26
-
摩熵咨询 20 8
-
摩熵咨询 20 11
-
摩熵咨询 34 56
-
颁布机构：国家药品监督管理局 2026-09-10
-
颁布机构：四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构：国家医保局 2026-07-31
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-09-28
-
2026-09-26
-
2026-09-26
-
摩熵咨询 35 71
-
摩熵咨询 28 60
-
摩熵咨询 34 42
-
颁布机构：国家市场监督管理总局 2026-09-18
-
颁布机构：国家市场监督管理总局 2026-09-17
-
颁布机构：国家市场监督管理总局 2026-08-10